| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/15/2007 | US20070036857 Pharmaceutical multiparticulate composition comprising mycophenolic acid or mycophenolate sodium and combination with rapamycin |
| 02/15/2007 | US20070036854 Therapeutic applications of pro-apoptotic benzodiazepines |
| 02/15/2007 | US20070036798 Method and composition for reconforming multi-epitopic antigens to initiate an immune response |
| 02/15/2007 | US20070036785 Pharmaceutical composition for treatment of diseases caused by IL-6 production |
| 02/15/2007 | US20070036783 Antibody complexes |
| 02/15/2007 | US20070036780 Modified proteins, designer toxins, and methods of making thereof |
| 02/15/2007 | US20070036768 Systems and methods for treating patients with processed lipoaspirate cells |
| 02/15/2007 | US20070036752 IL-2 fusion proteins with modulated selectivity |
| 02/15/2007 | US20070036735 Skin external preparation |
| 02/15/2007 | DE202006017823U1 Dietic food with increased effect of free radical binder, useful, e.g. for the treatment of allergic condition disease, comprises a protein and a sugar |
| 02/15/2007 | DE102005037733A1 Adeninderivate Adenine derivatives |
| 02/15/2007 | DE102005037499A1 Pyrazolderivate Pyrazole derivatives |
| 02/15/2007 | CA2619443A1 Glypican-3 (gpc3)-derived tumor rejection antigenic peptides useful for hla-a2-positive patients and pharmaceutical comprising the same |
| 02/15/2007 | CA2616069A1 Suppression of b-cell apoptosis in transgenic animals expressing humanized immunoglobulin |
| 02/14/2007 | EP1752465A2 Linear VH-CH1-VH-CH1 heavy chain antibody fragment |
| 02/14/2007 | EP1752445A1 New crystalline form III of agometalin, the process for its preparation and pharmaceutical compositions containing it |
| 02/14/2007 | EP1752444A1 New crystalline form IV of agometaline, the process for making it and pharmaceutical compositions containing it |
| 02/14/2007 | EP1752443A1 New crystalline form V of agometaline, the process for its preparation and the pharmaceutical compositions containing it |
| 02/14/2007 | EP1752189A2 Microprojection array having a beneficial agent containing coating |
| 02/14/2007 | EP1752148A2 Substituted phenethylsulfones for the treatment of inflammatory, infectious, immunological or malignant disease |
| 02/14/2007 | EP1751191A2 Antibodies to angiogenesis inhibiting domains of cd148 |
| 02/14/2007 | EP1751118A1 Pyrimidines for use as plk inhibitors |
| 02/14/2007 | EP1750764A2 Antibodies of angiogenesis inhibiting domains of cd148 |
| 02/14/2007 | EP1750715A1 Methods for treating mast cell disorders |
| 02/14/2007 | EP1750707A1 Immunostimulant composition comprising at least one toll-like receptor 7 or toll-like receptor 8 agonist and toll-like receptor 4 agonist |
| 02/14/2007 | EP1750692A2 Method of tonic treatment with oxyphenbutazone derivatives |
| 02/14/2007 | EP1750691A2 Compounds for treatment of aids and other diseases |
| 02/14/2007 | EP1651640B1 Nicotinamide derivatives useful as pde4 inhibitors |
| 02/14/2007 | EP1562944B1 Pyrazoloquinolines with immunomodulating activity |
| 02/14/2007 | EP1539796B1 Anti-inflammatory or anti-allergic androstane complexes |
| 02/14/2007 | EP1532121B1 New use of pyrimidine - or triazine- 2-carbonitiles for treating diseases associated with cysteine protease activity and novel pyrimidine-2-carbonitile derivatives |
| 02/14/2007 | EP1417228B1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 02/14/2007 | EP1368349B1 Xanthine derivative, production and use thereof as a medicament |
| 02/14/2007 | EP1345928B1 Pyrazole compounds useful as protein kinase inhibitors |
| 02/14/2007 | EP1343876B1 Modulators of activity of g-protein-coupled receptor kinases |
| 02/14/2007 | EP1343757B1 Indole derivatives |
| 02/14/2007 | EP1341790B1 Sulfonamido ether substituted imidazoquinolines |
| 02/14/2007 | EP1299378B1 Tetrahydropyridino or piperidino heterocyclic derivatives |
| 02/14/2007 | EP1296961B1 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists |
| 02/14/2007 | EP1278763B1 3-nitrogen-6,7-dioxygen steroids and uses related thereto |
| 02/14/2007 | EP1259234B9 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy |
| 02/14/2007 | EP1196182B1 Method for enhancing production performance in an animal |
| 02/14/2007 | EP1128813B1 An inhalation system |
| 02/14/2007 | EP1126836B1 Benzamide potassium channel inhibitors |
| 02/14/2007 | EP1124959B1 Cell surface molecule-induced macrophage activation |
| 02/14/2007 | EP1066055B1 Horse DNA vaccines containing the adjuvant acrylic acid, methacrylic acid or EMA (R) |
| 02/14/2007 | EP1063982B1 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders |
| 02/14/2007 | EP1035780B1 Method for purifying heat shock peptides complexes |
| 02/14/2007 | EP1009413B1 Use of immunostimulatory oligonucleotides for preventing or treating asthma |
| 02/14/2007 | EP0820283B1 Lactacystin analogs |
| 02/14/2007 | CN1914335A Antisense oligonucleotide modulation of STAT3 expression |
| 02/14/2007 | CN1911965A Binding domain-immunoglobulin fusion proteins |
| 02/14/2007 | CN1911931A Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
| 02/14/2007 | CN1911930A Chemokine receptor anagonists, methods and use therefor |
| 02/14/2007 | CN1911927A Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing tnf alpha levels |
| 02/14/2007 | CN1911443A Vaccine composition comprising tumor antigen and adjunvant composition |
| 02/14/2007 | CN1911439A Orally administered peptides to ameliorate atherosclerosis |
| 02/14/2007 | CN1911438A 血管新生诱导剂 Angiogenic inducer |
| 02/14/2007 | CN1911392A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911391A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911390A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911389A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911388A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911387A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911386A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911385A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911384A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911383A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911381A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911380A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911379A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911378A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911377A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911376A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911375A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911374A Injection contg. traditional Chinese medicine, and its pren. method |
| 02/14/2007 | CN1911372A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911371A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911370A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911369A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911368A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911367A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911365A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911266A Medicated composition contg. Brazil mushroom, Baifeng bean, and its prepn. method |
| 02/14/2007 | CN1911265A Composite medicine contg. Brazil mushroom, Baifeng bean and pearl micro-particle powder |
| 02/14/2007 | CN1911263A Clinical application of Yangchunpian |
| 02/14/2007 | CN1300315C Prothoracic gland hormone gene of calf of milk cow and its cloning method and use |
| 02/14/2007 | CN1300176C New saponin and its derivative, its preparation method and its use in medicine |
| 02/14/2007 | CN1300173C Human antibodies that bind huma TNF 'alpha' |
| 02/14/2007 | CN1300165C 3-b-d-ribofuranosylthiazolo [4,5-d] pyridimine nucleosides and uses thereof |
| 02/14/2007 | CN1300163C 3-hydroxy-chromogen ketoside and its preparation and use |
| 02/14/2007 | CN1300155C Clycerophosphoinositol derivatives as modulators of cytosolic phospholipase |
| 02/14/2007 | CN1300116C 1H-indazole compound |
| 02/14/2007 | CN1300114C Phenylpyridine carbonyl piperazine derivative |
| 02/14/2007 | CN1299754C Medicinal composition for treating theumalism and rheumatism diseases and preparing method thereof |
| 02/14/2007 | CN1299724C Health care products of lucid ganoderma |
| 02/14/2007 | CN1299683C Celecoxib compositions |
| 02/14/2007 | CN1299677C 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 02/13/2007 | US7176318 Processes for the production of fexofenadine |
| 02/13/2007 | US7176241 Aromatic or heteroaromatic compounds containing amide group are useful as inhibitor of dihydroorotate dehydrogenase |